Proteomics
Single-Cell Polyfunctional Strength Applied to Checkpoint & Antibody Based Immunotherapies

Featured Speaker: Will Singleterry, PhD, Director of Business Development, IsoPlexis

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this Webinar we discuss:

Evaluate T cell responses induced by various bispecific T cell engagers across phenotypes

Understand the heterogeneity of TIL polyfunctionality in solid tumors in response to checkpoint inhibitors

Uniquely correlate clinical anti-tumor responses with IsoPlexis data

Optimize combination cancer vaccines in melanoma using model systems

awards-bar-3-wide-color-right
awards-bar-4-wide-color-left
Watch the Webinar